Diabetes MellitusJohn A. Galloway, Janet H. Potvin, Charles R. Shuman Lilly Research Laboratories, 1988 - 335 pages |
From inside the book
Results 1-3 of 8
Page 106
... Insulin John A. Galloway , M.D. INTRODUCTION Approximately 20 million persons worldwide require insulin therapy to ... Discovery of Insulin Autumn 1987 marked the sixty - sixth anniversary of events in Toronto , Canada , which culminated ...
... Insulin John A. Galloway , M.D. INTRODUCTION Approximately 20 million persons worldwide require insulin therapy to ... Discovery of Insulin Autumn 1987 marked the sixty - sixth anniversary of events in Toronto , Canada , which culminated ...
Page 132
... history of the discovery of insulin and developmental landmarks in its chemistry have been discussed . The manufacture of human insulin by recombinant DNA methods and the first use of this technology to make a human phar- maceutical ...
... history of the discovery of insulin and developmental landmarks in its chemistry have been discussed . The manufacture of human insulin by recombinant DNA methods and the first use of this technology to make a human phar- maceutical ...
Page 133
... History of insulin therapy , in Schade DS , Santiago JV , Skyler JS , Rizza RA ( eds ) : Intensive Insulin Therapy . Amsterdam , Excerpta Medica , 1983 , chap 1 , pp 1-19 . 3. Bliss M : The Discovery of Insulin . Toronto , McClelland ...
... History of insulin therapy , in Schade DS , Santiago JV , Skyler JS , Rizza RA ( eds ) : Intensive Insulin Therapy . Amsterdam , Excerpta Medica , 1983 , chap 1 , pp 1-19 . 3. Bliss M : The Discovery of Insulin . Toronto , McClelland ...
Contents
Definition | 1 |
Chapter 2 iabetes Mellitus and Heredity | 15 |
Chapter 3 athophysiology of Diabetes Mellitus | 27 |
Copyright | |
15 other sections not shown
Common terms and phrases
abnormalities action activity agents antibodies associated betes blood glucose blood glucose concentrations body carbohydrate cause cells changes Chapter clinical complications continuous daily decrease determinations diabetes mellitus diabetic diet diabetic ketoacidosis diagnosis diet disease dose early effect exercise factors Figure given glucose tolerance glycemic glycosylated hemoglobin hormone human insulin hypoglycemia impaired important improved increased indicated individuals initial injection insulin infusion insulin receptor insulin resistance insulin secretion insulin therapy insulin-dependent levels lipoprotein liver meals measure metabolic methods mg/dl mmol/L monitoring muscle myocardial infarction needed normal obese occur oral patients with diabetes patients with Type plasma glucose pregnancy prevent production protein pump receptor reduced regular renal reported response retinopathy risk severe Source studies subcutaneous subjects Table therapy tion tissue treated treatment Type I diabetes Type II units urine usually values weight